Browse result page of THPdb

The total number entries retrieved from this search are 68

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
ID1028	ThPPIDTh1005	NameEtanercept	Peptide SequenceLPAQVAFTPYAPEPGSTCRL Full view	Length255	Functional ClassificationIIa	DiseaseImmunological	BrandEnbrel	CompanyImmunex Corp	Physical AppearanceLyophilized powder.	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents	TargetTumor necrosis factor,Tumor necrosis factor receptor superfamily member 1B,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c,Lymphotoxin-alpha,Low affinity immunoglobulin gamma Fc region re
ID1029	ThPPIDTh1005	NameEtanercept	Peptide SequenceLPAQVAFTPYAPEPGSTCRL Full view	Length255	Functional ClassificationIIa	DiseaseImmunological	BrandEnbrel Sureclick	CompanyN.A.	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents	TargetTumor necrosis factor,Tumor necrosis factor receptor superfamily member 1B,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c,Lymphotoxin-alpha,Low affinity immunoglobulin gamma Fc region re
ID1038	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandEligard	CompanyAtrix Labs/QLT In	Physical AppearanceSuspension	Route of AdministartionSubcutaneous Injection	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1039	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandEnantone	CompanyTakeda	Physical AppearanceSolution	Route of AdministartionInjection	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1040	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandLeuplin	CompanyTakeda	Physical AppearanceN.A.	Route of AdministartionInjection	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1041	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandLeuProMaxx	CompanyBaxter/Teva	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1042	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandLeupromer	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionInjection	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1043	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandLupron	CompanyAbbott/TAP Pharmaceuticals	Physical AppearanceN.A.	Route of AdministartionInjection	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1044	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandLutrate	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1045	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandMemryte	CompanyCuraxis	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1046	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandProstap 3	CompanyTakeda UK Limited	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1047	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandProstap SR	CompanyTakeda UK Limited	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1048	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandViadur	CompanyBayer AG	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1180	ThPPIDTh1023	NameAnakinra	Peptide SequenceMRPSGRKSSKMQAFRIWDVN Full view	Length153	Functional ClassificationIIa	DiseaseImmunological	BrandKineret	CompanyAmgen Inc	Physical AppearanceSterile, clear, colorless-to-white, preservative free solution	Route of AdministartionSubcutaneous (SC) administration	CategoryImmunosuppressive Agents, Anti-rheumatic agents	TargetInterleukin-1 receptor type 1
ID1187	ThPPIDTh1024	NameGramicidin D	Peptide SequenceVGALAVVVWLWLWLWX Full view	Length16	Functional ClassificationIIa	DiseaseInfectious	BrandNeosporin	CompanyPfizer	Physical AppearanceOintment	Route of AdministartionExternal use only	CategoryAnti-Bacterial Agents, Anti-infective, Topical, Antibiotic	TargetN.A.
ID1188	ThPPIDTh1024	NameGramicidin D	Peptide SequenceVGALAVVVWLWLWLWX Full view	Length16	Functional ClassificationIIa	DiseaseInfectious	BrandSofradex	CompanySanofi	Physical AppearanceSterile, clear, bright, colourless, aqueous solution	Route of AdministartionAuricular and Ocular use.	CategoryAnti-Bacterial Agents, Anti-infective, Topical, Antibiotic	TargetN.A.
ID1265	ThPPIDTh1038	NameOmalizumab	Peptide SequenceHeavy chain:EVQLVESG Full view	Length243	Functional ClassificationIIa	DiseaseImmunological	BrandXolair	CompanyGenentech Inc	Physical AppearanceSterile, white, preservative free, lyophilized powde	Route of AdministartionSubcutaneous Injection	CategoryAnti-Allergic Agents, Anti-asthmatic, Immuno-suppressive agents	TargetHigh affinity immunoglobulin epsilon receptor subunit alpha and beta
ID1327	ThPPIDTh1046	NameAbciximab	Peptide SequenceH ReoPro-like antibo Full view	Length218	Functional ClassificationIIa	DiseaseGenetic/Metabolic/Haemetological	BrandReoPro	CompanyEli Lilly and Company	Physical AppearanceClear, colorless, sterile, non-pyrogenic solution	Route of AdministartionIntravenous administartion	CategoryPlatelet Aggregation Inhibitors, Anticoagulants	TargetIntegrin beta-3,Integrin alpha-IIb,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immuno
ID1331	ThPPIDTh1047	NameAlpha-1-proteinase inhibitor	Peptide SequenceEDPQGDAAQKTDTSHHDQDH Full view	Length255	Functional ClassificationIIa	DiseaseMetabolic/Geneti/Respiratory	BrandAralast	CompanyBaxter	Physical AppearanceLyophilized powder	Route of AdministartionIntravenous infusion	CategorySerine Proteinase Inhibitors, Enzyme replacement agents, trypsin inhibitors	TargetNeutrophil elastase
ID1332	ThPPIDTh1047	NameAlpha-1-proteinase inhibitor	Peptide SequenceEDPQGDAAQKTDTSHHDQDH Full view	Length255	Functional ClassificationIIa	DiseaseMetabolic/Geneti/Respiratory	BrandProlastin	CompanyTalecris Biotherapeutics C formerly Bayer	Physical AppearanceLyophilized powder	Route of AdministartionIntravenous infusion	CategorySerine Proteinase Inhibitors, Enzyme replacement agents, trypsin inhibitors	TargetNeutrophil elastase
ID1368	ThPPIDTh1054	NameInfliximab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseImmunological	BrandREMICADE	CompanyCentocor Inc	Physical AppearanceSterile, white, lyophilized powder, following reconstitution with 10 mL of Sterile Water for Injection, USP, the resulting pH is approximately 7.2.	Route of AdministartionIntravenous infusion	CategoryAntirheumatic Agents, Anti-Inflammatory Agents, Non-Steroidal, Dermatologic Agents, Gastrointestinal Agents and Immunosuppressive Agents	TargetTumor necrosis factor
ID1385	ThPPIDTh1061	NameTrastuzumab	Peptide SequenceLight chain 1: DIQMT Full view	Length1364	Functional ClassificationIIa	DiseaseCancer	BrandHerceptin	CompanyGenentech	Physical AppearanceSterile, white to pale yellow, preservative-free lyophilized powder	Route of Administartion Intravenous administration	CategoryAntineoplastic Agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor,Insulin-degrading enzyme,HLA class II histocompatibility antigen, DQ alpha 2 chain,HLA class II histocompatibility antigen, DQ beta 1 chain,Retinoblastoma-associated protein,Cathepsin D,Carboxypeptidase E,Neuroendocrine convertase 2,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-related protein 2,Insulin-like growth factor-binding protein 7,Synaptotagmin-like protein 4
ID1389	ThPPIDTh1062	NameRituximab	Peptide SequenceHeavy Chain: QVQLQQP Full view	Length664	Functional ClassificationIIa	DiseaseCancer/Immunological	BrandRituxan	CompanyBiogen Idec Inc., and Genentech USA, Inc	Physical AppearanceSterile, clear, colorless, preservative-free liquid concentrate	Route of Administartion Intravenous administration	CategoryAntineoplastic Agents, Immunologic Factors and Antirheumatic Agents	TargetB-lymphocyte antigen CD20,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c, Receptor tyrosine-protein kinase erbB-2,Epidermal growth factor receptor,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor I
ID1398	ThPPIDTh1063	NameBasiliximab	Peptide SequenceHeavy Chain: QLQQSGT Full view	Length657	Functional ClassificationIIa	DiseaseImmunological	BrandSimulect	CompanyNovartis	Physical AppearanceSterile lyophilisate which is available in 6 mL colorless glass vials and is available in 10 mg and 20 mg strength	Route of Administartionintravenous infusion mainly or bolus (if no allergic reactions occurs)	CategoryImmunosuppressive Agents	TargetN.A.
ID1400	ThPPIDTh1064	NameMuromonab	Peptide SequenceHeavy Chain: QVQLQQS Full view	Length664	Functional ClassificationIIa	DiseaseImmunological	BrandORTHOCLONE OKT3 STERILE SOLUTION	CompanyCentocor Ortho Biotech, L.P.	Physical AppearanceSterile Solution is a murine monoclonal antibody to the CD3 antigen of human T cells which functions as an immunosuppressant.	Route of AdministartionFor Intravenous Use Only	CategoryImmunologic Factors and Immunosuppressive Agents	TargetN.A.
ID1403	ThPPIDTh1065	NameDigoxin Immune Fab (Ovine)	Peptide SequenceHeavy Chain: EVQLQQS Full view	Length438	Functional ClassificationIIa	DiseaseCardiac	BrandDIGIBIND	CompanyGalaxo Smith Kline	Physical AppearanceSterile lyophilized powder of antigen binding fragments (Fab) derived from specific antidigoxin antibodies raised in sheep.	Route of AdministartionIntravenous infusion after reconstitution with Sterile Water for Injection	CategoryAntidotes	TargetT-cell surface glycoprotein CD3 delta chain, T-cell surface glycoprotein CD3 epsilon chain, T-cell surface glycoprotein CD3 gamma chain, T-cell surface glycoprotein CD3 zeta chain, Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1r subcomponent, Complement C1q subcomponent subunit A, Complement C1q subcomponent subunit B, Complement C1q subcomponent subunit C, Low affinity immunoglobulin gamma Fc region receptor III-A, Complement C1s subcomponent, High affinity immunoglobulin gamma Fc receptor I, Low affinity immunoglobulin gamma Fc region receptor II-a, Low affinity immunoglobulin gamma Fc region receptor II-b, Low affinity immunoglobulin gamma Fc region receptor II-c
ID1404	ThPPIDTh1065	NameDigoxin Immune Fab (Ovine)	Peptide SequenceHeavy Chain: EVQLQQS Full view	Length438	Functional ClassificationIIa	DiseaseCardiac	BrandDigiFab	Company Protherics Inc	Physical AppearanceSterile, purified, lyophilized preparation of digoxin-immune ovine Fab (monovalent) immunoglobulin fragments.ÂÂÂ	Route of AdministartionIntravenous administrationÂÂÂ	CategoryAntidotes	TargetT-cell surface glycoprotein CD3 delta chain, T-cell surface glycoprotein CD3 epsilon chain, T-cell surface glycoprotein CD3 gamma chain, T-cell surface glycoprotein CD3 zeta chain, Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1r subcomponent, Complement C1q subcomponent subunit A, Complement C1q subcomponent subunit B, Complement C1q subcomponent subunit C, Low affinity immunoglobulin gamma Fc region receptor III-A, Complement C1s subcomponent, High affinity immunoglobulin gamma Fc receptor I, Low affinity immunoglobulin gamma Fc region receptor II-a, Low affinity immunoglobulin gamma Fc region receptor II-b, Low affinity immunoglobulin gamma Fc region receptor II-c
ID1409	ThPPIDTh1067	NameDaptomycin	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseInfectious	BrandCUBICIN	CompanyCubist Pharmaceuticals, Inc	Physical AppearanceSterile, preservative-free, pale yellow to light brown, lyophilized cake containing approx 500 mg of daptomycin	Route of AdministartionIntravenous(IV) Injection	CategoryN.A.	TargetB-lymphocyte antigen CD20,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
ID1415	ThPPIDTh1069	NamePegvisomant	Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view	Length191	Functional ClassificationIIa	DiseaseHormonal	BrandSOMAVERT	CompanyPfizer	Physical AppearanceSterile, white lyophilized powderÂÂÂ	Route of AdministartionSubcutaneous Injection	CategoryHormone Replacement Agents	TargetB-lymphocyte antigen CD20,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
ID1431	ThPPIDTh1073	NameAlemtuzumab	Peptide SequenceHeavy Chain 1: QVQLQ Full view	Length2839	Functional ClassificationIIa	DiseaseCancer	BrandCAMPATH	CompanyGenzyme Corporation	Physical AppearanceSterile, clear, colorless, isotonic solution (pH 6.8-7.4)	Route of AdministartionIntravenous infusion	CategoryN.A.	TargetN.A.
ID1432	ThPPIDTh1073	NameAlemtuzumab	Peptide SequenceHeavy Chain 1: QVQLQ Full view	Length2389	Functional ClassificationIIa	DiseaseCancer	BrandLEMTRADA	CompanyGenzyme Corporation	Physical AppearanceLEMTRADA is a sterile, clear and colorless to slightly yellow, solution (pH 7.2±0.2) for infusion.	Route of AdministartionIntravenous infusion	CategoryNA	TargetNA
ID1442	ThPPIDTh1078	NameEfalizumab	Peptide SequenceLight Chain:DIQMTQSP Full view	Length229	Functional ClassificationIIa	DiseaseImmunological	BrandRAPTIVA	CompanyGenentech, Inc.	Physical AppearanceSterile, white to off-white, lyophilized powder in single-use glass vials	Route of AdministartionSubcutaneous injection.ÂÂÂ	CategoryImmunosuppressive Agents	TargetIduronic acid
ID1449	ThPPIDTh1081	NameAntithymocyte Globulin	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseImmunological	BrandAntithymocyte globulin	CompanyPfizer	Physical AppearanceN.A.	Route of AdministartionIntravenous infusion	CategoryImmunologic Factors and Immunosuppressive Agents	TargetN.A.
ID1462	ThPPIDTh1088	NameEnfuvirtide	Peptide SequenceYTSLIHSLIEESQNQQEKNE Full view	Length36	Functional ClassificationIIa	DiseaseInfectious	Brand`FUZEON	CompanyTrimeris, Roche	Physical AppearanceWhite to off-white, sterile, lyophilized powder.	Route of AdministartionSubcutaneous injection	CategoryHIV Fusion Inhibitors	TargetOxytocin receptor,Oxytocin-neurophysin 1, Envelope glycoprotein
ID1466	ThPPIDTh1090	NameDaclizumab	Peptide SequenceQVQLVQSGAEVKKPGSSVKV Full view	Length674	Functional ClassificationIIa	DiseaseImmunologicals	BrandZenapax	CompanyRoche	Physical AppearanceClear, sterile, colorless concentrate for further dilution and intravenous administration	Route of AdministartionIntravenous injection	CategoryImmunosuppressive Agents	TargetFusion glycoprotein F0,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
ID1468	ThPPIDTh1091	NameBevacizumab	Peptide SequenceDIQMTQSPSSLSASVGDRVT Full view	Length214	Functional ClassificationIIa	DiseaseCardiac	BrandAvastin	CompanyGenentech	Physical AppearanceSlightly opalescent, colorless to pale brown, sterile, pH 6.2 solution for intravenous infusion	Route of AdministartionIntravenous infusion	CategoryAngiogenesis Inhibitors	TargetInterleukin-2 receptor subunit alpha,Interleukin-2 receptor subunit beta,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
ID1474	ThPPIDTh1094	NamePanitumumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseCancer	BrandVectibix	CompanyAmgen Inc	Physical AppearanceSterile, colorless, pH 5.6 to 6.0 liquid for intravenous (IV) infusion, which may contain a small amount of visible translucent-to-white, amorphous, proteinaceous, panitumumab particulates	Route of AdministartionN.A.	CategoryN.A.	TargetEpidermal growth factor receptor
ID1475	ThPPIDTh1095	NameRanibizumab	Peptide SequenceLight Chain SASQDISN Full view	Length447	Functional ClassificationIIa	DiseaseHematological/Eye Disorder	BrandLucentis	CompanyGenentech	Physical AppearanceSterile, colorless to pale yellow solution	Route of AdministartionIntravitreal injection	CategoryOphthalmics	TargetVascular endothelial growth factor A
ID1495	ThPPIDTh1102	NameAbatacept	Peptide SequenceMHVAQPAVVLASSRGIASFV Full view	Length357	Functional ClassificationIIa	DiseaseImmunological	BrandORENCIA	CompanyBristol-Myers Squibb	Physical AppearanceLyophilized powder, supplied as a sterile, white, preservative-free, lyophilized powder for intravenous administration	Route of AdministartionIntravenous infusion and Subcutaneous injection	CategoryAntirheumatic Agents and Immunosuppressive Agents	TargetT-lymphocyte activation antigen CD80,T-lymphocyte activation antigen CD86
ID1529	ThPPIDTh1108	NamePegaptanib	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseHematological/Eye Disorder	BrandMacugen	CompanyGilead Sciences	Physical AppearanceSterile, aqueous solution containing pegaptanib sodium for intravitreous injection	Route of AdministartionIntravitreal injection	CategoryIntended for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS.	TargetN.A.
ID1533	ThPPIDTh1112	NameNatural Alpha Interferon Or Multiferon	Peptide SequenceInteferon alpha-1: Full view	Length997	Functional ClassificationIIa	DiseaseCancer/Infectious	BrandIntron/ Roferon-A	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionSubcutaneous injection, Intravenous injection, Intramuscular injection	CategoryN.A.	TargetN.A.
ID1534	ThPPIDTh1113	NameGlatiramer Acetate	Peptide SequenceEAYKAAEKAYAAKEAAKEAA Full view	Length52	Functional ClassificationIIa	DiseaseNeurological Disorder	BrandCopaxone	CompanyTeva Pharmaceutical Industries	Physical AppearanceClear, colorless to slightly yellow, sterile, nonpyrogenic solution	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetN.A.
ID1536	ThPPIDTh1115	NameTeicoplanin	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseInfectious	BrandTargocid	CompanyNPS Pharmaceuticals	Physical AppearanceLight yellow solid	Route of AdministartionIntravenous injection, Intramuscular injection	CategoryAnti-Bacterial Agents	TargetD-Ala-D-Ala moiety of NAM/NAG peptide subunits of peptidoglycan
ID1550	ThPPIDTh1119	NameTocilizumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseImmunological	BrandACTEMRA	CompanyGenentech	Physical AppearanceSterile, preservative-free solution, colorless to pale yellow liquid, with a pH of about 6.5	Route of AdministartionIntravenous infusion, Subcutaneous injection	CategoryN.A.	TargetInterleukin-6 receptor subunit alpha
ID1562	ThPPIDTh1122	NameRilonacept	Peptide Sequencerilonacept|Homo sapi Full view	Length880	Functional ClassificationIIa	DiseaseImmunological	BrandArcalyst	CompanyRegeneron Pharmaceuticals	Physical AppearanceSterile, white to off-white, lyophilized powder	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents	TargetInterleukin-1 beta,Interleukin-1 alpha,Interleukin-1 receptor antagonist protein
ID1596	ThPPIDTh1126	NameBelatacept	Peptide SequenceMHVAQPAVVLASSRGIASFV Full view	Length357	Functional ClassificationIIa	DiseaseImmunological	BrandNulojix	CompanyBristol-Myers Squibb	Physical AppearanceSterile, white or off-white lyophilized powder	Route of AdministartionIntravenous injection	CategoryAntirheumatic Agents and Immunosuppressive Agents	TargetT-lymphocyte activation antigen CD86,T-lymphocyte activation antigen CD80
ID1609	ThPPIDTh1132	NameBelimumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseImmunological	BrandBenlysta	CompanyGlaxoSmithKline	Physical AppearanceSterile, white to off-white, preservative-free, lyophilized powder	Route of AdministartionIntravenous infusion	CategoryMonoclonal antibodies	TargetTumor necrosis factor ligand superfamily member 13B
ID1627	ThPPIDTh1138	NameRaxibacumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseImmunological/Infectious	BrandRAXIBACUMAB	CompanyGSK	Physical AppearanceSterile, liquid formulation in single-dose vials	Route of AdministartionN.A.	CategoryAnti-Infective Agents and Monoclonal antibodies	TargetProtective antigen
ID1644	ThPPIDTh1147	NameNatalizumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseGenetic/Immunological	BrandTysabri	CompanyBiogen Idec Inc.	Physical AppearanceSterile, colorless, and clear to slightly opalescent concentrate	Route of AdministartionIntravenous infusion	CategoryImmunosuppressive agents	TargetN.A.
ID1648	ThPPIDTh1148	NameAliskiren	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseMetabolic	BrandTekturna	CompanyPhysicians Total Care, Inc.	Physical AppearanceLight-pink, biconvex round tablet	Route of AdministartionOral route	CategoryRenin inhibitor	TargetRenin